metastatic pancreatic cancer market

View All

Horizon, Viela Deal; Concert Schizophrenia Drug Flop; Gilead, Gritstone Deal
Horizon, Viela Deal; Concert Schizo Drug Flop; Gilead Deals with Arcus and Gritstone

Horizon Therapeutics Bolsters its Rare Disease Portfolio in a $3B Viela Bio Buyout Horizon Therapeutics has announced to acquire Viela Bio for about $3.1 billion to augment its portfolio and pipeline of treatments for rare diseases. The shares of Viela Bio skyrocketed more than 52% in premarket trading after the...

Find More

Metastatic Pancreatic Cancer market
Metastatic Pancreatic Cancer Market Size: Emerging therapies, Unmet needs and Forecast analysis

Pancreas is a gland which has two components exocrine component and endocrine component.  The exocrine component which is responsible for making proteins/ enzymes and releasing them into small intestines for easy digestion. On the other hand, the endocrine component of the pancreas is responsible for making ho...

Find More